5. Beers Criteria:
? 因為clonidine有中樞抑制效果,跟心跳慢及姿勢
性低血壓的風險,所以不建議作為65歲以上長者
第一線的降血壓藥
? (Ref.) Clonidine is identified in the Beers Criteria as a potentially
inappropriate medication in patients 65 years and older (independent
of diagnosis or condition) for hypertension treatment due to high risk
of CNS adverse effects and risk of bradycardia and orthostatic
hypotension associated with central alpha blockers. Avoid clonidine as
a first-line antihypertensive (Beers Criteria [AGS 2019]).